NEW YORK (360Dx) – Royal Philips said today that it is collaborating with PathAI, a company that develops artificial intelligence for pathology, to develop solutions that make diagnosis of cancer and other diseases more precise and accurate. 

The companies aim to build deep-learning applications in computational pathology that may be applied to massive pathology data sets to better inform diagnostic and treatment decisions. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.